The Valley Desk

NCT06430905 · Interventional trial

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Overall registry status Terminated

Phase 1

Conditions Human Immunodeficiency Virus (HIV) Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov